Purple Biotech
PPBT
Purple Biotech (PPBT) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$2.90
- EPS estimate
- −$2.60
- EPS surprise
- −11.54%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 14, 2025 | −$2.60 | −$2.90 | −11.54% | $0.00 | SEC |
| Q2 2025 | Aug 6, 2025 | −$2.10 | −$4.00 | −90.48% | $0.00 | SEC |
| Q1 2025 | May 21, 2025 | $0.00 | −$1.70 | +0.00% | $0.00 | SEC |
| Q4 2024 | Mar 10, 2025 | −$2.20 | −$2.60 | −18.18% | $0.00 | SEC |
| Q2 2024 | Aug 16, 2024 | −$23.00 | −$18.00 | +21.74% | $0.00 | SEC |
| Q1 2024 | May 21, 2024 | −$38.00 | −$28.00 | +26.32% | $0.00 | SEC |
| Q4 2023 | Mar 5, 2024 | −$38.00 | −$38.00 | +0.00% | $0.00 | SEC |
| Q3 2023 | Invalid Date | −$45.33 | −$46.00 | −1.47% | $0.00 | — |
| Q2 2023 | Aug 22, 2023 | −$51.33 | −$50.00 | +2.60% | $0.00 | SEC |
| Q1 2023 | May 16, 2023 | −$72.00 | −$50.00 | +30.56% | $0.00 | SEC |
| Q4 2022 | Feb 8, 2023 | −$50.00 | −$66.00 | −32.00% | $0.00 | SEC |
| Q3 2022 | Nov 8, 2022 | −$42.00 | −$54.00 | −28.57% | $0.00 | — |
| Q2 2022 | Aug 4, 2022 | $0.00 | −$40.00 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Purple Biotech (PPBT) last report earnings?
Purple Biotech last reported on Nov 14, 2025, covering fiscal Q3 2025.
Did PPBT beat earnings estimates?
No. Purple Biotech reported EPS of −$2.90 for Q3 2025 against a −$2.60 estimate — a 11.54% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.